logo
AI Icon𝛼SK or Search
ENTITY
Akeso

Akeso (9926 HK)

367
Analysis
Health Care • China
Akeso is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative antibody drugs. It develops treatments for major diseases such as cancer, autoimmune diseases, inflammation, and metabolic diseases, with key products including cadonilimab, ivonescimab, and penpulimab. The company was founded in 2012 and is headquartered in Zhongshan, Guangdong, China.
more
Company Presentation • 27 Aug 2026 22:00

H1 2026

Company Presentation • 26 Aug 2025 12:30

H1 2025

Company Presentation • 09 Jun 2021 14:00

ASCO 2021 Presentation

Company Presentation • 07 Jun 2022 14:00

ASCO 2022 Presentation

Company Presentation • 09 Jan 2024 15:00

J.P.Morgan 42nd Annual Healthcare Conference Presentation

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x